508 related articles for article (PubMed ID: 8876155)
21. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
[TBL] [Abstract][Full Text] [Related]
22. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
[TBL] [Abstract][Full Text] [Related]
23. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase.
Shimada M; Ishibashi S; Inaba T; Yagyu H; Harada K; Osuga JI; Ohashi K; Yazaki Y; Yamada N
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7242-6. PubMed ID: 8692976
[TBL] [Abstract][Full Text] [Related]
24. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
[TBL] [Abstract][Full Text] [Related]
25. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
Vaziri ND; Liang K; Parks JS
Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
[TBL] [Abstract][Full Text] [Related]
27. LCAT cholesterol esterification is associated with the increase of ApoE/ApoA-I ratio during atherosclerosis progression in rabbit.
Carlucci A; Cigliano L; Maresca B; Spagnuolo MS; Di Salvo G; Calabrò R; Abrescia P
J Physiol Biochem; 2012 Dec; 68(4):541-53. PubMed ID: 22562159
[TBL] [Abstract][Full Text] [Related]
28. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
[TBL] [Abstract][Full Text] [Related]
29. Dietary fatty acid modification of HDL phospholipid molecular species alters lecithin: cholesterol acyltransferase reactivity in cynomolgus monkeys.
Thornburg JT; Parks JS; Rudel LL
J Lipid Res; 1995 Feb; 36(2):277-89. PubMed ID: 7751815
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.
Duverger N; Kruth H; Emmanuel F; Caillaud JM; Viglietta C; Castro G; Tailleux A; Fievet C; Fruchart JC; Houdebine LM; Denefle P
Circulation; 1996 Aug; 94(4):713-7. PubMed ID: 8772693
[TBL] [Abstract][Full Text] [Related]
31. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
[TBL] [Abstract][Full Text] [Related]
32. Effects of diazepam (Valium) on aortic atherogenesis and plasma lecithin: cholesterol acyltransferase activity in cockerels fed an atherogenic diet.
Wong HY; Loo G; Sherief HT; Zhuang HZ
Artery; 1992; 19(1):39-46. PubMed ID: 1739387
[TBL] [Abstract][Full Text] [Related]
33. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
[TBL] [Abstract][Full Text] [Related]
34. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
[TBL] [Abstract][Full Text] [Related]
35. Effects of hepatic HDL-related mRNAs on plasma prebeta HDL in cholesterol-fed rabbits.
Sugano M; Makino N; Yanaga T
Artery; 1997; 22(4):182-205. PubMed ID: 9576025
[TBL] [Abstract][Full Text] [Related]
36. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport.
Francone OL; Haghpassand M; Bennett JA; Royer L; McNeish J
J Lipid Res; 1997 Apr; 38(4):813-22. PubMed ID: 9144096
[TBL] [Abstract][Full Text] [Related]
37. Compromised LCAT function is associated with increased atherosclerosis.
Hovingh GK; Hutten BA; Holleboom AG; Petersen W; Rol P; Stalenhoef A; Zwinderman AH; de Groot E; Kastelein JJ; Kuivenhoven JA
Circulation; 2005 Aug; 112(6):879-84. PubMed ID: 16061733
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of lipoprotein lipase in transgenic rabbits inhibits diet-induced hypercholesterolemia and atherosclerosis.
Fan J; Unoki H; Kojima N; Sun H; Shimoyamada H; Deng H; Okazaki M; Shikama H; Yamada N; Watanabe T
J Biol Chem; 2001 Oct; 276(43):40071-9. PubMed ID: 11477088
[TBL] [Abstract][Full Text] [Related]
40. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
